Guy Neev

Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA.

Azimuth Technologies Ltd. is a world leader in target acquisition, fire coordination, navigation, and orientation solutions for defense applications. Azimuth solutions are based on the first-hand battlefield experience of their staff and are the systems of choice for the IDF. It focuses on the development of equipment which is effective and affordable. Its systems are designed to enable modern armies-artillery, armor, mortar, intelligence, special forces, mounted infantry, supporting airborne platforms to maximize the effectiveness of their fire. Azimuth systems create a common language for the various units participating in the modern, integrated battlefield and directly target the needs of mobile and rapid deployment forces. Its navigation and orientation technologies deliver the information commanders need for flexible maneuver and full situational awareness. The company was founded by Mr. Shlomi Reisman in 1987 and is headquartered in Raanana, Israel.

Aummune Ltd. develops pre-clinical cancer therapeutics. The company was founded by Guy Neev and Marius Nacht and is headquartered in Rehovot, Israel.

Curesponse Ltd. develops a technology to improve cancer research and drug diagnostics. Its services include personalized cancer treatment regimen. The company was founded by Guy Neev, Seth Salpeter, and Ravid Straussman on November 5, 2017 and is headquartered in Tel Aviv, Israel.